Stripe, Anthropic, and OpenAI are backing an effort to stop respiratory infections

Stripe announced on March 13, 2024, its commitment to fund a new $500 million nonprofit organization named Intercept, dedicated to preventing respiratory infections like the common cold and flu, with an ultimate goal of eradicating respiratory viruses. The initiative is also backed by significant contributions from Anthropic, the OpenAI Foundation, and Flu Lab, alongside investments from Bill Gates and traders at Jane Street Capital. Intercept will allocate funds and investments towards developing preventative measures, including vaccines, and implementing large-scale air-cleaning systems in public spaces such as schools and offices. Nan Ransohoff, a Stripe executive leading the project, highlighted that respiratory infections are often underestimated in their societal burden, noting that individuals spend an average of 5% of their lifetime battling these illnesses. The challenge in developing preventative solutions, particularly vaccines, stems from the vast number of viruses causing colds, exceeding 200 types, with rhinoviruses being the most prevalent, making it economically unviable for pharmaceutical companies to focus on individual virus prevention. This contrasts with Stripe's previous $1.8 billion Frontier program, which aimed to stimulate advancements in carbon removal technology to combat climate change, indicating a strategic shift towards addressing public health challenges with similar large-scale funding approaches.